Market closed
Genus/£GNS
08:00
10:10
12:15
14:25
16:30
1D1W1MYTD1Y5YMAX
About Genus
Genus PLC, trading under the ticker GNS on the London Stock Exchange, specializes in animal genetics and biotechnology. The company, founded in 1994 and headquartered in Basingstoke, United Kingdom, operates across multiple countries offering genetically superior pig and cattle breeding stock along with state-of-the-art in vitro fertilization products. Genus PLC aims to empower customers in the livestock sector to enhance the efficiency and profitability of their operations by providing innovative genetic solutions and services.
Ticker
£GNS
Sector
Trading on
LSE
Industry
Biotechnology
Headquarters
Employees
3,500
Website
Genus Metrics
BasicAdvanced
£1.1B
Market cap
138.49
P/E ratio
£0.12
EPS
0.37
Beta
£0.32
Dividend rate
1.94%
Dividend yield
Price and volume
Market cap
£1.1B
Beta
0.37
52-week high
£23.78
52-week low
£14.78
Average daily volume
124K
Dividend rate
£0.32
Financial strength
Current ratio
1.8
Quick ratio
1.13
Long term debt to equity
50.064
Total debt to equity
53.539
Dividend payout ratio (TTM)
265.82%
Interest coverage (TTM)
2.25%
Management effectiveness
Return on assets (TTM)
3.31%
Return on equity (TTM)
0.43%
Valuation
Price to earnings (TTM)
138.487
Price to revenue (TTM)
1.619
Price to book
1.97
Price to tangible book (TTM)
2.9
Price to free cash flow (TTM)
212.256
Dividend yield (TTM)
1.94%
Growth
Revenue change (TTM)
-3.03%
Earnings per share change (TTM)
-76.44%
3-year revenue growth (CAGR)
5.21%
3-year earnings per share growth (CAGR)
-45.12%
What the Analysts think about Genus
Analyst Ratings
Analyst ratings (Buy, Hold, Sell) for Genus stock.
Genus Financial Performance
Income Statement
Revenues and expenses
QuarterlyAnnual
Q3 24
QoQ growth
Revenue
$37B
-39.75%
Net income
$45B
107.52%
Profit margin
37.65%
6.78%
Genus Earnings Performance
Earnings per share (EPS)
Company profitability
QuarterlyAnnual
Q4 23
Q1 24
Q2 24
Q3 24
Q4 24
Actual
$3.69
$2.85
$2.45
$2.42
-
Expected
$3.55
$2.61
$2.05
$2.31
$3.94
Surprise
3.94%
9.20%
19.51%
4.63%
-
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Market data provided by CBOE Europe
FAQs
What’s the current market cap for Genus stock?
Genus (GNS) has a market cap of £1.1B as of December 12, 2024.
What is the P/E ratio for Genus stock?
The price to earnings (P/E) ratio for Genus (GNS) stock is 138.49 as of December 12, 2024.
Does Genus stock pay dividends?
Yes, the Genus (GNS) stock pays dividends to shareholders. As of December 12, 2024, the dividend rate is £0.32 and the yield is 1.94%. Genus has a payout ratio of 265.82% on a trailing twelve-month basis.
When is the next Genus dividend payment date?
The next Genus (GNS) dividend payment date is unconfirmed.
What is the beta indicator for Genus?
Genus (GNS) has a beta rating of 0.37. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.